LIFETECH SCI.DL-00000125 (81X) - Total Liabilities
Based on the latest financial reports, LIFETECH SCI.DL-00000125 (81X) has total liabilities worth €1.54 Billion EUR (≈ $1.80 Billion USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore LIFETECH SCI.DL-00000125 equity growth rate to track the company's year-over-year net asset growth rate.
LIFETECH SCI.DL-00000125 - Total Liabilities Trend (2021–2025)
This chart illustrates how LIFETECH SCI.DL-00000125's total liabilities have evolved over time, based on quarterly financial data. See how much free cash does LIFETECH SCI.DL-00000125 generate to measure how efficiently the company converts operating cash flow to free cash.
LIFETECH SCI.DL-00000125 Competitors by Total Liabilities
The table below lists competitors of LIFETECH SCI.DL-00000125 ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Shenzhen Comix Group Co Ltd
SHE:002301
|
China | CN¥4.96 Billion |
|
BIOCYTOGEN PHARMA. H YC1
F:I54
|
Germany | €1.54 Billion |
|
Solomon Technology Corp
TW:2359
|
Taiwan | NT$3.83 Billion |
|
Beijing Hualu Baina Film TV
SHE:300291
|
China | CN¥829.31 Million |
|
Archean Chemical Industries Limited
NSE:ACI
|
India | Rs7.32 Billion |
|
Advanced Wireless Semiconductor Co
TWO:8086
|
Taiwan | NT$2.29 Billion |
|
Sunflag Iron And Steel Company Limited
NSE:SUNFLAG
|
India | Rs23.28 Billion |
|
Xiamen Guang Pu Electronics Co Ltd
SHE:300632
|
China | CN¥1.02 Billion |
Liability Composition Analysis (2021–2025)
This chart breaks down LIFETECH SCI.DL-00000125's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see how much is LIFETECH SCI.DL-00000125 worth.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.57 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.44 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.31 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how LIFETECH SCI.DL-00000125's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for LIFETECH SCI.DL-00000125 (2021–2025)
The table below shows the annual total liabilities of LIFETECH SCI.DL-00000125 from 2021 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | €1.54 Billion ≈ $1.80 Billion |
+7.89% |
| 2024-12-31 | €1.42 Billion ≈ $1.67 Billion |
+3.83% |
| 2023-12-31 | €1.37 Billion ≈ $1.60 Billion |
+78.45% |
| 2022-12-31 | €769.05 Million ≈ $899.10 Million |
+17.66% |
| 2021-12-31 | €653.61 Million ≈ $764.14 Million |
-- |
About LIFETECH SCI.DL-00000125
LifeTech Scientific Corporation, an investment holding company, develops, manufactures, and trades in interventional medical devices for cardiovascular and peripheral vascular diseases and disorders in Mainland China, Europe, Rest of Asia, India, South America, Africa, and internationally. It operates through Structural Heart Diseases Business, Peripheral Vascular Diseases Business, and Cardiac P… Read more